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General Information.  Commercial reagents were purified prior to use following
the guidelines of Perrin and Armarego.1  Organic solutions were concentrated under
reduced pressure on a Büchi rotary evaporator.  Chloroform was distilled from calcium
hydride prior to use.  Chromatographic purification of products was accomplished using
forced-flow chromatography on Iatrobeads 6RS–8060 according to the method of Still.2
Thin-layer chromatography (TLC) was performed on EM Reagents 0.25 mm silica gel
60-F plates.  Visualization of the developed chromatogram was performed by
fluorescence quenching or anisaldehyde stain.  Gas liquid chromatography (GLC) assays
to determine enantiometric excess were developed using racemic samples.
1H and 13C NMR spectra were recorded on Varian Mercury 300 (300 MHz and 75
MHz respectively) as noted, and are internally referenced to residual protio solvent
signals.  Data for 1H are reported as follows: chemical shift (d ppm), multiplicity (s =
singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant
(Hz) and assignment.  Data for 13C NMR are reported in terms of chemical shift.  IR
spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in
terms of frequency of absorption (cm-1).  Mass spectra were obtained from the California
Institute of Technology Mass Spectral facility.  Gas liquid chromatography (GLC) was
performed on Hewlett-Packard 6850 Series gas chromatography equipped with a split-
mode capillary injection system and flame ionization detectors using a Bodman
Chiraldex G-TA (30 m 0.25 mm) column.
General Procedure: A 10 mL round-bottom flask equipped with a magnetic stir
bar and charged with (5S)-5-benzyl-2,2,3-trimethylimidazolidin-4-one (16.6 mg, 0.05
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mmol) and acetone (2 mL) is allowed to cool to –30 °C for five minutes prior to addition
of 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one (361 mg, 1.2 mmol). The aldehyde
substrate (1 mmol) was added to the yellow homogenous solution. The resulting mixture
was stirred at –30 °C until the reaction is determined to be complete by GLC, upon which
time the mixture is a pale yellow heterogeneous solution.  The reaction was then eluted
with Et2O and passed through Iatrobeads (8 g), and the resulting organics were carefully
concentrated in vacuo (using an ice bath).  The resulting residue was purified by
Iatrobeads chromatography (solvents noted) and organics carefully concentrated in vacuo
with an ice bath to provide the title compounds.  The enantioselectivity was determined
by chiral GLC analysis.
5-Methoxymethoxy-pentanal:  To a flask containing 1,5-pentanediol (34 mL,
330 mmol) and NEt3 (13.7 mL, 99 mmol) in CH2Cl2 (150 mL) was slowly added
chloromethyl methyl ether (5.0 ml, 65.8 mmol) at 0 °C.  The solution was allowed to
warm to room temperature and stirred for 4 hours.  The reaction was then treated with
saturated aqueous NH4Cl, extracted with CH2Cl2 (2 ¥ 100 mL), dried over Na2SO4, and
concentrated.  Iodobenzene diacetate (8.4 g, 26.2 mmol) was then added to a solution of
the crude product (3.5 g, 24 mmol) and TEMPO (0.37 g, 2.4 mmol) in CH2Cl2 (50 mL).3
The reaction was stirred for 12 hours and then diluted with CH2Cl2 (250 mL).  The
mixture was washed with a saturated aqueous solution of Na2S2O3 (150 mL) and
extracted with CH2Cl2 (2 ¥ 100 mL).  The combined organics were washed with saturated
aqueous NaHCO3 (150 mL), dried over NaSO4, and concentrated in vacuo.  The resulting
residue is purified by silica gel chromatography (40% Et2O/ pentane) and the organics
carefully concentrated in vacuo with an ice bath to provide the title compound.  IR (film)
2941, 2871, 2720, 1725, 1454, 1383, 1353, 1262, 1201, 1138, 1122, 1078, 1035, 991.9,
905.0, 868.3, 814.2 cm-1; 1H NMR (300 MHz, CDCl3) d 9.74 (t, 1H, J = 1.5 Hz, CHO),
4.58 (s, 2H, CH2OMe), 3.51 (t, 2H, J = 6.5 Hz, CH2CH2O), 3.33 (s, 3H, CH3), 2.46 (td, J
= 1.5, 7.3 Hz, 2H), 1.76- 1.54 (m, 4H, (CH2)2CH2CHO); 13C NMR (75 MHz, CDCl3) d
202.3, 96.4, 67.1, 55.1, 43.5, 29.1, 18.9; HRMS (CI) exact mass calculated for (C7H13O3)
requires m-1/z 145.0865, found m-1/z 145.0862.
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(S)-2-Chloro-octanal (Table 3, entry 1): Prepared according to the general
procedure from octylaldehyde (156 µL, 1.00 mmol) for 6 h to provide the title compound
as a colorless oil (115.2 mg, 71% yield, 92% ee) after Iatrobeads chromatography (2.5%
Et2O/ pentane).  IR (film) 3385, 2957, 2927, 2858, 1458, 1400, 1378, 1343, 1138, 1102,
1069, 879.9 cm-1; 1H NMR (300 MHz, CDCl3) d 9.52 (d, 1H, J = 2.7 Hz CHO), 4.19
(ddd, 1H,  J = 2.7, 5.6, 8.2 Hz, CHCl), 2.06- 1.95 (m, 1H, ClCCH2), 1.90- 1.79 (m, 1H,
ClCCH2), 1.62- 1.26 (m, 8H, (CH2)4CH3), 0.92 (t, J = 6.9 Hz, 3H, CH3); 13C NMR (75
MHz, CDCl3) d 195.4, 64.0, 32.1, 31.5, 28.6, 25.5, 22.5, 14.0; HRMS (CI) exact mass
calculated for (C8H15ClO) requires m/z 162.0811, found m/z 167.0812.  [a]D = –35.47 (c
= 1.0, CHCl3).  The enantiomeric ratio was determined by GLC using a Bodman
Chiraldex G-TA (30 m x 0.25 mm) column (50 °C isotherm, 1 mL/min);  (R) isomer tr =
75.5 min and (S) isomer tr = 81.4 min.
(S)-2-Chloro-7-octenal (Table 3, entry 2): Prepared according to the general
procedure from oct-7-enal (126 mg, 1.00 mmol) for 8 h to provide title compound as a
colorless oil (114 mg, 76% yield, 92% ee) after Iatrobeads chromatography (2% Et2O/
pentane).  IR (film) 3853, 3676, 3406, 2970, 2928, 2855, 2357, 2325, 1279, 1102, 1076,
905.2 cm-1; 1H NMR (300 MHz, CDCl3) d 9.45 (d, 1H, J = 2.2 Hz, CHO), 5.83-5.69 (m,
1H, CH2CH=CH2), 4.97 (dd, 2H, J = 1.7, 10.1 Hz, CH=CH2), 4.13 (ddd, 1H, J = 2.2, 6.7,
7.1 Hz, CHCl), 2.09-1.99 (m, 2H, CH2CH=CH2), 2.02-1.93 (m, 1H, ClCCH2), 1.88-1.76
(m, 1H, ClCCH2) 1.62-1.38 (m, 4H, CH2(CH2)2CH2); 13C NMR (75 MHz, CDCl3) d
195.5, 138.4, 115.1, 64.1, 33.5, 32.1, 28.4, 25.2; HRMS (CI) exact mass calculated for
(C8H13ClO) requires m/z [M-Cl] =127.0759, found m/z 127.0759.  [a]D = –40.59 (c = 1.0,
CHCl3). The enantiomeric ratio was determined by GLC using a Bodman Chiraldex G-
TA (30 m x 0.25 mm) column (50 °C isotherm, 1 mL/min);  (R) isomer tr = 89.3 min and
(S) isomer tr = 91.4 min.
(S)-Chloro-cyclohexyl-acetaldehyde (Table 3, entry 3): Prepared according to
the general procedure from cyclohexyl-acetaldehyde3 (138 µL, 1.00 mmol) for 8 h to
provide the title compound as a colorless oil (139.8 mg, 87% yield, 94% ee) after
Iatrobeads chromatography (2.5% Et2O/ pentane).  IR (film) 3374, 2930, 2855, 1451,
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1378, 1112, 1080, 890.3, 733.0 cm-1; 1H NMR (300 MHz, CDCl3) d 9.50 (d, 1H, J = 3.5
Hz, CHO), 4.00 (dd, 1H, J = 3.5, 6.4 Hz, CHCl), 2.07- 1.92 (m, 1H, ClCCH), 1.90- 1.66
(m, 4H), 1.43- 1.11 (m, 6H); 13C NMR (75 MHz, CDCl3) d 195.8, 69.4, 40.2, 29.7, 28.3,
25.9, 25.8, 25.6; HRMS (CI) exact mass calculated for (C7H12Cl) requires m/z 131.0628,
found m/z 131.0626.  [a]D = –6.01 (c = 1.0, CHCl3).  The enantiomeric ratio was
determined by GLC using a Bodman Chiraldex G-TA (30 m x 0.25 mm) column (60 °C
isotherm, 1 mL/min);  (R) isomer tr = 101.3 min and (S) isomer tr = 111.0 min.
(S)-Chloro-tricyclo[3.3.1.10,0]dec-1-yl-acetaldehyde (Table 3, entry 4):
Prepared according to the general procedure from tricyclo[3.3.1.10,0]dec-1-yl-
acetaldehyde4 (174 µL, 1.00 mmol) at –40 °C using (5S ) - 5 - b e n z y l - 2 , 2 , 3 -
trimethylimidazolidin-4-one (66.4 mg, 0.2 mmol) for 24 h to provide the title compound
as a colorless oil (136.5 mg, 85% yield, 95% ee).  The excess 2,3,4,5,6,6-hexachloro-2,4-
cyclohexadien-1-one was consumed by addition of propionaldehyde (29 µL, 0.40 mmol).
The reaction was quenched by filtration through Iatrobeads (8 g) eluting with Et2O and
concentrated in vacuo.  The resulting residue was purified by Iatrobeads chromatography
(2.5% Et2O/ pentane).  IR (film) 2905, 2851, 1730, 1456, 1345, 1106, 1064, 1004, 976.2,
762.9 cm-1; 1H NMR (300 MHz, CDCl3) d 9.52 (d, 1H, J = 4.8 Hz, CHO), 3.70 (d, 1H, J
= 4.8 Hz, CHCl), 2.10- 2.02 (m, 3H), 1.81-1.63 (m, 12H); 13C NMR (75 MHz, CDCl3) d
195.7, 73.8, 38.8, 37.1, 36.5, 28.0; HRMS (CI) exact mass calculated for (C12H17ClO)
requires m/z 212.0968, found m/z 212.0970.  [a]D = +30.02 (c = 1.0, CHCl3).  Reduction
of the title compound to the corresponding alcohol and cyclization with aqueous 50%
KOH provided the epoxide 2-tricyclo[3.3.1.10,0]dec-1-yl-oxirane which matched literature
data.5  The enantiomeric ratio of the epoxide was determined by GLC using a Bodman
Chiraldex G-TA (30 m x 0.25 mm) column (100 °C isotherm, 1 mL/min); (S) isomer tr =
49.3 min and (R) isomer tr = 51.6 min.
(S)-2-Chloro-hydrocinnamaldehyde (Table 3, entry 5): Prepared according to
the general procedure from hydrocinnamaldehyde (62 mg, 0.50 mmol) in d6-acetone for 6
h.  To reaction flask was added benzyl methyl ether (61 mg, 0.50 mmol).  The title
compound was provided (92% NMR yield, 92% ee) then isolated as a colorless oil (80%
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ee) after Iatrobeads chromatography (2% Et2O/ pentane).  The title compound was
identical in all respects to the known literature compound with regards to NMR and
HRMS data.6  IR (film) 3511, 2360, 2341, 1717, 1653, 1540, 1417, 1377, 1277, 1191,
1111, 767.7, 701.6 cm-1; [a]D = –8.84 (c = 1.0, CHCl3). The enantiomeric ratio was
determined by GLC using a Bodman Chiraldex G-TA (30 m x 0.25 mm) column (60 °C
isotherm, 1 mL/min);  (R) isomer tr = 234.3 min and (S) isomer tr = 245.4 min.
(S)-2-Chloro-5-methoxymethoxy-pentanal (Table 3, entry 6): Prepared
according to the general procedure from 5-methoxymethoxy-pentanal (170 µL, 1.00
mmol) at –40 °C for 12 h to provide the title compound as a colorless oil (139.8 mg, 94%
yield, 93% ee) after Iatrobeads chromatography (40% Et2O/ pentane).  IR (film) 3401,
2932, 2885, 2826, 1736, 1445, 1386, 1346, 1149, 1110, 1040, 919.5, 775.0 cm-1; 1H
NMR (300 MHz, CDCl3) d 9.53 (d, 1H, J = 2.1 Hz, CHO), 4.62 (s, 2H, CH2OMe), 4.26
(ddd, 1H, J = 2.1, 5.1, 8.5 Hz, CHCl), 3.59 (t, 2H, J = 5.8 Hz, CH2CH2O), 3.37 (s, 3H,
CH3), 2.22- 2.09 (m, 1H), 2.00- 1.68 (m, 3H); 13C NMR (75 MHz, CDCl3) d 195.0, 96.4,
66.5, 63.7, 55.3, 29.1, 25.8; HRMS (CI) exact mass calculated for (C7H14ClO3) requires
m/z 181.0632, found m/z 181.0632.  [a]D = –12.68 (c = 1.0, CHCl3).  The enantiomeric
ratio was determined by GLC using a Bodman Chiraldex G-TA (30 m x 0.25 mm)
column (50 °C isotherm, 1 mL/min);  (R) isomer tr = 260.4 min and (S) isomer tr = 267.5
min.
(S)-2-Chloro-6-oxo-heptanal (Table 3, entry 7): Prepared according to the
general procedure from 6-oxo-heptanal7 (128 mg, 1.0 mmol) for 12 h to provide title
compound as a colorless oil (134 mg, 78% yield, 87% ee) after Iatrobeads
chromatography (35% Et2O/ pentane).  IR (film) 3420, 2933, 2855, 2360, 1732, 1715,
1418, 1363, 1162 cm-1; 1H NMR (300 MHz, CDCl3) d 9.47 (d, 1H, J = 2.3 Hz, CHO),
4.16 (dd, 1H, J = 2.2, 7.2 Hz, CHCl), 2.47 (t, 2H, J = 7.2 CH2CO), 2.12 (s, 3H, CH3),
2.03-1.93 (m, 1H), 1.85-1.57 (m, 3H); 13C NMR (75 MHz, CDCl3) d 207.9, 195.1, 63.8,
42.7, 31.4, 30.1, 19.9; HRMS (CI) exact mass calculated for (C7H15ClO2) requires m/z
=160.0655, found m/z 160.0658.  [a]D = –49.93 (c = 1.0, CHCl3).  The enantiomeric ratio
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was determined by GLC using a Bodman Chiraldex G-TA (30 m x 0.25 mm) column (75
°C isotherm, 1 mL/min);  (R) isomer tr = 144.1 min and (S) isomer tr = 149.3 min.
(R)-2-Chloro-(R)-3-phenylbutyraldehyde (Equation 3): Prepared according to
the general procedure from (S)-3-phenylbutyraldehyde (74 mg, 0.50 mmol) for 6 h to
provide the title compound as a colorless oil (65 mg, 71% yield, 7:1 anti:syn, 98% ee)
after Iatrobeads chromatography (1% Et2O/ pentane).  IR (film) 3821 3751, 2973, 2831,
1733, 1495, 1455, 762.5, 700.0 cm-1; 1H NMR (300 MHz, CDCl3) d 9.37 (d, 1H, J = 3.0
Hz, CHO), 7.37-7.23 (m, 5H, ArH ), 4.29 (dd, 1H, J= 3.0, 6.6 CHCl), 3.47 (qd, J = 6.6,
7.2 Hz, 1H, CHCH3), 1.46 (d, J = 7.2 Hz, 3H, CH3);  13C NMR (75 MHz, CDCl3) d
195.2, 140.3, 129.9, 128.8, 128.5, 128.4, 127.9, 127.7, 68.7, 42.3, 18.7; HRMS (CI) exact
mass calculated for (C10H11ClO) requires m/z =182.0502, found m/z 182.0498.  [a ]D =
–3.86 (c = 1.0, CHCl3).  Product ratio was determined by GLC using a Bodman Chiraldex
G-TA (30 m x 0.25 mm) column (75 °C isotherm, 1 mL/min); anti adduct (2R, 3R) tr =
115.5 min, syn adduct (2S, 3R) tr = 189.2 min.
(S)-2-Chloro-(R)-3-phenylbutyraldehyde (Equation 4): Prepared according to
the general procedure from (S)-3-phenylbutyraldehyde (74 mg, 0.50 mmol) for 6 h to
provide pure title compound as a colorless oil (72 mg, 79% yield, 24:1 syn:anti, 98% ee)
after Iatrobeads chromatography (1% Et2O/ pentane).  IR (film) 3821 3751, 2973, 2831,
1733, 1495, 1455, 762.5, 700.0 cm-1; 1H NMR (300 MHz, CDCl3) d 9.37 (d, 1H, J = 3.0
Hz CHO), 7.37-7.23 (m, 5H, ArH ), 4.29 (dd, 1H, J = 3.0, 6.6 Hz, CHCl), 3.47 (qd, 1H, J
= 6.6, 7.2 Hz, CHCH3), 1.4 (s, 3H, CH3);  13C NMR (75 MHz, CDCl3) d195.2, 140.3,
129.9, 128.8, 128.5, 128.4, 127.9, 127.7, 68.7, 42.3, 18.7; HRMS (CI) exact mass
calculated for (C10H11ClO) requires m/z =182.0502, found m/z 182.0498. [a]D = –2.31 (c
= 1.0, CHCl3).  The enantiomeric and diastereomeric ratios were determined by GLC
using a Bodman Chiraldex G-TA (30 m x 0.25 mm) column (75 °C isotherm, 1 mL/min);
syn adduct (2S, 3R) tr = 111.8, anti adduct (2R, 3R) tr = 190.2 min.
Stereochemical Analysis
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Procedure for Conversion to Epoxide:  To a solution of (S)-2-chloroaldehyde (0.5
mmol) in CH2Cl2 (0.5 mL) and absolute ethanol (0.5 mL) was added sodium borohydride
(0.5 mmol) at 0 °C.  After 15 min, the resulting solution was treated with saturated
aqueous NaHCO3 and the mixture was extracted with CH2Cl2.  The crude mixture was
then concentrated in vacuo.  The resultant yellow oil was then added to a round-bottom
flask equipped with a magnetic stir bar.  To the flask was added a solution of aqueous
50% KOH (2 mL) and allowed to stir at room temperature for 4 hours.  At this time the
resulting mixture was washed with Et2O (3 x 5 mL) before the organics were
concentrated in vacuo.  The resulting residue was purified by silica gel chromatography
(5% Et2O/ pentane).
(R)-Benzyl oxirane:  Prepared according to the procedure for conversion to epoxide
from (S)-2-chloro-hydrocinnamaldehyde (77 mg, 0.5 mmol) to afford the title compound
as a colorless oil (37 mg, 55% yield). The title compound was identical in all respects to
the known literature compound.  [a]D = +10.1 (c = 1.94, EtOH); reported rotation for (S)-
benzyl oxirane [a]D = -17.3 (c = 1.94, EtOH). 8
(R)-2-Hexyloxirane:  Prepared according to the procedure for conversion to epoxide
from (S)-2-chloro-octanal (81 mg, 0.5 mmol) to afford the title compound as a colorless
oil (42 mg, 66% yield).  The title compound was identical in all respects to the known
literature compound.  [a]D = +6.2 (c = 1.8, CHCl3); reported rotation for (R)-2-
hexyloxirane [a]D = +7.4 (c = 4.5, CHCl3). 9
(R)-2-Cyclohexyloxirane:  Prepared according to the procedure for conversion to
epoxide from (S)-chloro-cyclohexyl-acetaldehyde (80 mg, 0.5 mmol) to afford the title
compound as a colorless oil (24 mg, 38% yield). The title compound was identical in all
respects to the known literature compound.  [a]D = –2.1 (c = 0.88, CHCl3); reported
rotation for (S)-2-cyclohexyloxirane [a]D = +2.1 (c = 0.88, CHCl3). 10
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